Supreme Court Directs Time-Bound Committee to Regulate Unethical Pharmaceutical Marketing Practices and Protect Public Health

Highlights of the Judgment:
- Examination of the constitutional right to health under Article 21 and the regulation of pharmaceutical marketing practices.
- Judicial review and the doctrine of separation of powers concerning executive policy formulation in public health.
- Invocation of powers under Articles 32 and 142 to mandate a time-bound consultative committee on industry ethics.
- Evaluation of the enforcement and adequacy of self-regulatory codes like the Uniform Code for Pharmaceutical Marketing Practices.